← Back to Company DatabaseVisit Website
BioNTech
mRNA-based immunotherapies and personalized cancer vaccines.
PublicMainz, GermanyFounded 2008
About
BioNTech is a biotechnology company pioneering mRNA-based therapies for cancer and infectious diseases. Known widely for its COVID-19 vaccine partnership with Pfizer, the company's core focus has always been individualized cancer immunotherapy. BioNTech develops personalized mRNA cancer vaccines, CAR-T cell therapies, and novel immunomodulators for oncology.
Total Funding
$1.5BKey Product
Individualized neoantigen-specific mRNA cancer vaccinesGeography
EuropeKey Investors
PfizerFidelityRedmile Group
Focus Areas
Treatment (Therapeutics)Drug Discovery
Technology
ImmunotherapyCell TherapyTargeted Therapy
Cancer Types
SkinPan-cancer
Last updated: Feb 4, 2026